Disruptive biomedical technology is bringing drastic changes to eye treatment. Opharmic applies its patented innovative ultra-sound technology to administer eye drugs in a non-invasive way. It negates the need for risky injections into the eyeball. The business matching support from HKSTP was instrumental for this breakthrough technology to gain traction.


arrow up arrow down arrow left arrow right icon close icon text icon help icon hkstp